chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Three days after he received the Tdap, he developed left-sided axillary and supraclavicular lymphadenopathy, swelling, and tenderness, which was the site of injection. Then a week after the vaccine he developed spells of numbness that started in the back and then progressed to his upper and lower extremities. Immediately after each numbness spell, he developed a migraine headache with visual aura.  Then on 12/18/2020 he had an ischemic stroke with no known etiology.
upper respiratory symptom like running nose; tremendously itching all over her body; headache; fever; body ache; This spontaneous case was reported by a health care professional and describes the occurrence of RHINORRHOEA (upper respiratory symptom like running nose), PRURITUS (tremendously itching all over her body), HEADACHE (headache), PYREXIA (fever) and MYALGIA (body ache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (upper respiratory symptom like running nose), PRURITUS (tremendously itching all over her body), HEADACHE (headache), PYREXIA (fever) and MYALGIA (body ache). At the time of the report, RHINORRHOEA (upper respiratory symptom like running nose), PRURITUS (tremendously itching all over her body), HEADACHE (headache), PYREXIA (fever) and MYALGIA (body ache) outcome was unknown. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Jan-2021 and was forwarded to Moderna on 26-Jan-2021.    This spontaneous case was reported by a health care professional and describes the occurrence of RHINORRHOEA (upper respiratory symptom like running nose), PRURITUS (tremendously itching all over her body), HEADACHE (headache), PYREXIA (fever) and MYALGIA (body ache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (upper respiratory symptom like running nose), PRURITUS (tremendously itching all over her body), HEADACHE (headache), PYREXIA (fever) and MYALGIA (body ache). At the time of the report, RHINORRHOEA (upper respiratory symptom like running nose), PRURITUS (tremendously itching all over her body), HEADACHE (headache), PYREXIA (fever) and MYALGIA (body ache) outcome was unknown. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   No treatment details were reported.
Moderna COVID?19 Vaccine EUA  Apart from the fatigue, sore arm and feverishness I had on the day of the vaccination, I woke the next day with what looked like Subconjunctival hemorrhage in my right eye. It was a bright red spot in my cornea and both my eyes were sore.   Since then, the hemorrhage has spread within my right eye. My eyes are still sore and I get a sharp/shooting pain in my right eye intermittently. I also feel some soreness in my right temple and under the ear.
soreness in the shoulder; being disoriented and dizzy, not to the point of spinning but disorientated; being disoriented and dizzy, not to the point of spinning but disorientated; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (being disoriented and dizzy, not to the point of spinning but disorientated), DIZZINESS (being disoriented and dizzy, not to the point of spinning but disorientated) and ARTHRALGIA (soreness in the shoulder) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Dec-2021 at 10:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Dec-2021, the patient experienced DISORIENTATION (being disoriented and dizzy, not to the point of spinning but disorientated) and DIZZINESS (being disoriented and dizzy, not to the point of spinning but disorientated). On an unknown date, the patient experienced ARTHRALGIA (soreness in the shoulder). At the time of the report, DISORIENTATION (being disoriented and dizzy, not to the point of spinning but disorientated) and DIZZINESS (being disoriented and dizzy, not to the point of spinning but disorientated) had not resolved and ARTHRALGIA (soreness in the shoulder) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.   The patient experienced dizziness and disorientation at the afternoon of 31-Dec-2021.  The patient would make an appointment with the local general practitioner and asked whether the event was a side effect of Moderna vaccine or not. The patient was physically fine, could walk, but would not drive now because of this reason.
Report side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Report side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report side effect). At the time of the report, VACCINATION COMPLICATION (Report side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products was provided by the reporter. No treatment information was provided by the reporter.
8-21-06 rash appeared on neck.  Following day, rash appeared over entire body 8-22-06 emergency room visit, 8-26-06 emergency room visit medication prescribed hydroxyzine and Medrol.
She had a fever of 102.5, cough, runny nose, and congestion. She dropped her fever, but still had a stuffy nose, cough, and congestion. She was not prescribed medication, but we gave her over the counter MUCINEX. She got better and then this all came back on 12/17/2022. This time she had a headache, body aches, congestion, and cough. We gave her a COVID-19 test on 12/27/22, at home and it was negative. We took her to the doctor, and she was tested for COVID-19, Flu, and Strep. All came back negative. I can't recall the date that she had all the tests though. She was not prescribed medication, but we are giving her MUCINEX and VICK'S vapor rub.
FLU-LIKE SYMPTOMS SUCH AS ACHES AND PAIN AND TIREDNESS.
Causing The Vaccine Landing On My Arm Instead of It Going Into The Patient's Deltoid; Initial Report Received on 28-Sep-2022, 03-Oct-2022, 04-Oct-2022 and 18-Nov-2022  This is a spontaneous report, received via a MedWatch 3500A from the FDA MedWatch Program.  The report was reported by a patient safety specialist regarding a patient who received HEPLISAV-B for hepatitis B immunization.   There was no medical history reported for the patient.  Concomitant medications were not reported.  On 09-Sep-2022, a dose of HEPLISAV B (Lot #937783, expiration date Dec 2025, NDC #43528-003-01), route not specified, was administered in the left deltoid for hepatitis B immunization by the medical assistant.  During administration, when attempting to administer HEPLISAV-B into a patient's left deltoid, the liquid of the vaccine shot out of where the syringe's plain tip and the needle's hub meet, causing the vaccine to land on the medical assistant's arm instead of going into the patient's deltoid. The needle was inserted into the arm, and when medical assistant pressed the plunger to administer the vaccine, a large amount of clear fluid squirted out the side between the hub of the needle and pre-filled syringe. It was reported that it appeared to be the full 0.5 ml as it was dripping from the medical assistant's arm and on her scrubs. This was immediately reported to provider, who advised new vaccine be administered and this was done with no issues.  The outcome of the adverse event was not reported.  The lot was investigated in CN-000018. No lot impact was found.  No further information was available at the time of the report.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Pt recvd 3 doses of Engerix-B & did not convert; recvd a 4th dose; titer not yet checked;
Pt recvd vax on 19MAY92 & exp soreness & pain @ the inject site; on 20MAY92 exp numbness & a tingling sensation that radiated down lt arm into lt hand; pt had trouble sleeping because of arm soreness; seen by MD who found sx to be unrelated
Type 1 diabetes diagnosis... symptoms of hyperglycemia (excessive urination) presented the day after receiving 2nd dose.
COVID test positive; COVID test positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Jan2022 14:00 (Lot number: FL3997) at the age of 72 years as dose 3 (booster), single, administered in arm left, administration date 27Mar2021 14:00 (Lot number: ER8730) as dose 2, single and administered in arm left, administration date 27Feb2021 14:00 (Lot number: EL9266) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history, no known allergies. Concomitant medication(s) included: FINASTERIDE; ATORVASTATIN; METPROLOL; VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]. The patient did not receive other vaccine in 4 weeks. The patient had no covid-19 prior vaccination. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 01Feb2022, outcome "unknown" and all described as "COVID test positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (01Feb2022) positive, notes: Covid test type post vaccination. The events were reported as Non-serious, No Results in death, No Life threatening, No Caused/prolonged hospitalization, No Disabling/Incapacitating, No Congenital anomaly/birth defect.
Patient describes pain and arm stiffness in deltoid starting the evening of the day of vaccination. This got significantly worse the following day- she was unable to move her entire upper arm and was very stiff. This has persisted- currently at day #13 of symptoms with no improvement. No fevers. Patient has had the flu shot every year for at least 10 years and has never had a reaction like this.
I developed a rash of tiny, itchy bumps above my left elbow. The rash isn't discolored, it's the same color as my skin so not too visible. But I can feel the bumps from my elbow to about a quarter of the way up the top half of my arm. The bumps are extremely itchy.
local site injection reaction- swelling, induration, erythematous, tender to touch.   Other symptoms noted include- body aches, fatigue, malaise.
From initial information received on 27/Apr/2005 from a health care professional regarding an adverse event, it was reported that a 36 year old female patient received a dose of DECAVAC, lot number U1210BA, administered intra-muscularly in the afternoon on 25/Apr/2005. The site of administration was unknown as per the reporter. One day later, on 26/Apr/2005, the patient phoned the physician's office and complained that she was unable to lift her arm and was sweating. She was sent to the emergency room. At the time of this report, the patient had not recovered from these events. Follow-up information received on 11/Oct/2005 from a physician. Per the reporter, the patient did not have any illnesses at the time of the vaccination. She had a neurology and orthopedic surgeon consult on 03/May/2005 and a magnetic resonance imaging test on 04/May/2005. The patient had a full recovery from these events as of August 2005. No further information is expected.
3 hours after shot I became dizzy & disoriented...my hands very shaking & heart rate & blood pressure high. I felt like I was on a drug. I was hearing & seeing things very differently.
red eye hematoma; severe pain in the arm and leg, stabbing/sling pain/sore arm; Severe allergic reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONJUNCTIVAL HAEMORRHAGE (red eye hematoma), PAIN IN EXTREMITY (severe pain in the arm and leg, stabbing/sling pain/sore arm) and HYPERSENSITIVITY (Severe allergic reaction) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced CONJUNCTIVAL HAEMORRHAGE (red eye hematoma), PAIN IN EXTREMITY (severe pain in the arm and leg, stabbing/sling pain/sore arm) and HYPERSENSITIVITY (Severe allergic reaction). At the time of the report, CONJUNCTIVAL HAEMORRHAGE (red eye hematoma), PAIN IN EXTREMITY (severe pain in the arm and leg, stabbing/sling pain/sore arm) and HYPERSENSITIVITY (Severe allergic reaction) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was included. Treatment included acetaminophen and prednisone (not sure with the dose) and put cream on it to lessen the pain.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. On an unknown dates, the patients were vaccinated with an improperly stored doses of VAQTA (dose, frequency, route of administration, lot# and expiration date were not reported). No adverse effects were reported. Product quality complain (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
she only had a bit issue moving her arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (she only had a bit issue moving her arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A, 008B21-2A, 017F21A and 056M21A) for COVID-19 prophylaxis.     The patient's past medical history included Lip swelling and Swelling of tongue. Concurrent medical conditions included Allergy to animal dander, Latex allergy, Grass allergy, Ragweed allergy, Allergy to animal dander, Allergic to dogs, Environmental allergy, Lactose intolerance, Fruit allergy, Rubber sensitivity, Fruit allergy, Fruit allergy and Spice allergy.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (she only had a bit issue moving her arm). At the time of the report, LIMB DISCOMFORT (she only had a bit issue moving her arm) had resolved.            It was reported that patient did not receives any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant product use was not provided by the reporter.  It was reported that Since she was very allergic to a lot of things physican took precautions and listed the ingredients of the first dose, asking her if she had a previous reaction to any of the ingredients, she said no and then she got the vaccine without any adverse events. After second dose it was less traumatic to get the vaccine since she knew that with the first one was ok, she was prepared and hydrated to avoid inconveniences, and she only had a bit issue moving her arm but then she felt fine. With the rest of the vaccines she also felt a bit of an issue in her arm but next day she was fine.  Treatment information was not provided.   This case was linked to MOD-2023-747721 (Patient Link).   Reporter did not allow further contact
Second Moderna COVID-19 vaccine created adverse reaction.  Similar to flu symptoms,; however, I began hearing a constant, high-frequency static sound in my head. It has been continuous all day, all night, for 5 weeks now. It never goes away! It seems like tinnitus. I am concerned because it hasn?t gone away and is always present (for 5 weeks now!)
Fever (100.7 as highest temperature) that lasted for more than 24 hours;  Mild body aches when fever lasted Very mild nausea that lasted for about a week
Narrative:  67 YOM with hx of RA, colon polyps - tubular adenoma (cscope under MAC 9-18, repeat 3 yrs), Essential htn, COPD, Rheumatoid Arthritis, depression, anticoagulation - for blue toe syndrome, GERD, insomnia, hypercholesterolemia, bil foot, paresthesia, hand weakness - atrophy of muscles of hands, headaches, tobacco use : quit smoking 2015, ED, memory loss, h/o pneumonia, hearing loss passed away at Hospital on 6/24/2021. Pt received COVID vaccines on 1/22/2021 and 2/25/2021. Death appears unrelated to vaccines.
Information has been received from a medical assistant referring to a 4 year old female patient. There was no pertinent medical history. The patient's concurrent conditions included seasonal allergies. On 21-MAY-2018, the patient was vaccinated with a dose of VARIVAX, (lot # N029628, expiry date 23-OCT-2019), subcutaneous in the left anterolateral thigh, for routine vaccination. The vaccine was reconstituted with sterile diluent (MERCK), (lot # N030572, expiry date 20-APR-2020). Concomitant therapies included VERAMYST and SINGULAIR. On an unknown date in May 2018, 12 hours after the vaccine administration, the patient developed "cellulitis" at the injection site. The patient was seen in the physician's office on 23-MAY-2018 and was prescribed an unspecified dose of clindamycin palmitate HCL and an epinephrine pen. At the time of reporting the patient's outcome for the cellulitis was not recovered. No causality assessment between the event and the vaccine was provided by the reporter. Upon internal review, the cellulitis was considered medically significant as the patient received treatment with epinephrine pen. This is one of two reports from the same reporter source, linked to case # 1805USA012539. Sender's Comments: US-009507513-1805USA012539.
Since the 1st incident June 16, every time I am in an indoor space for prolonged periods with vaccinated individuals, I experienced swelling in my ankles within 24 hours. It took me awhile to pinpoint the cause of this reaction, however, after several meet ups with friends and family members who were vaccinated, I began to isolate the cause. Side effects occur more so if skin-to-skin contact such as a hug is involved. This needs to be addressed immediately, as when I began to conduct further research, I found out I was not the only person experiencing adverse reactions with close contact with vaccinated individuals. Please refer to pages in the following Pfizer documentation which discusses the ability for a transmission (I assume spike protein, however, transmitted toxin is inclusive at this time).
Splitting up phlegm; Upset tummy; Vomiting; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Splitting up phlegm), ABDOMINAL DISCOMFORT (Upset tummy), VOMITING (Vomiting) and NAUSEA (Nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for Diabetes.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PRODUCTIVE COUGH (Splitting up phlegm), ABDOMINAL DISCOMFORT (Upset tummy), VOMITING (Vomiting) and NAUSEA (Nausea). At the time of the report, PRODUCTIVE COUGH (Splitting up phlegm), ABDOMINAL DISCOMFORT (Upset tummy), VOMITING (Vomiting) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient has a history of diabetes and on insulin.  Patient has experienced vomiting and nausea consistently in the morning and at night. Patient was spitting up phlegm and has an upset tummy.  No treatment information was provided.   This case was linked to MOD-2021-040002 (E2B Linked Report).; Sender's Comments:  MOD-2021-040002:partner case
This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 1-year-old patient who received Hepatitis A vaccine (batch number CN3G5) for prophylaxis. On 22-FEB-2023, the patient received the 2nd dose of Hepatitis A vaccine. On an unknown date, an unknown time after receiving Hepatitis A vaccine, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK receipt date: 14-Apr-2023. The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug. Sender's Comments: US-GSK-US2023054677: same reporter; US-GSK-US2023AMR055743: same reporter.
Upon waking the morning after my vaccine, I experienced arthralgia, mainly in the knees, myalgia, injection site pain, head heaviness, palpitations/premature ventricular contractions, and general tiredness/malaise.  All AEs lasted the entire day until I went to sleep at 10:30 PM, and all were resolved upon waking the following morning at 7:00 AM.
4 inch rash at injection site.  does not hurt or itch.  I noticed it on the 8th day after vaccination date.
Patient seen in clinic for continued left arm pain at injection site  since vaccination on 11/23/21 making daily activities difficult such as dressing and bathing.
"Called out this shift due to chills and body aches most likely associated with the vaccine. "